The Impact of Coronavirus Disease 2019 Nonpharmaceutical Interventions on Incidence of Acute Gastroenteritis and Acute Respiratory Infections Among US Military and Dependents.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 40132639.
- Also identified by DOI 10.1093/infdis/jiaf153 and PMC identifier 12247794.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nonpharmaceutical interventions (NPIs) for coronavirus disease 2019 resulted in the reduction of many viral diseases aside from severe acute respiratory syndrome coronavirus 2, but their impact on the United States military or beneficiary population has not been assessed. Using TRICARE data (2016-2023), we modeled changes in acute gastroenteritis (AGE) and acute respiratory infection (ARI) encounters pre- and postpandemic. In 2020, AGE and ARI encounters decreased substantially (rate ratio [RR] = 0.50 [95% confidence interval {CI}, .31-.80]; RR = 0.60 [95% CI, .41-.88], respectively). By 2022, AGE remained suppressed while ARI had rebounded. Since 2022, AGE encounters among military personnel remained reduced compared to beneficiaries. NPIs had a greater, lasting effect on AGE than ARI encounters.
Medical subject headings
- Military Personnel
- COVID-19
- Respiratory Tract Infections
- Gastroenteritis